Effects of a Transitional Palliative Care Model on Patients With End-stage Renal Failure (ESRF)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02139917|
Recruitment Status : Completed
First Posted : May 16, 2014
Last Update Posted : March 22, 2019
- To compare the effects of customary care and an interventional Home-based Palliative Renal Program (HBPRP) for ESRF patients
To compare the effects of customary care and Home-based Palliative Program (HBPP) for ESRF patients
- To explore the lived experiences of patients with ESRF. Hypothesis The transitional renal palliative care model is associated with decreased in unscheduled hospital readmission, reduce length of stay as well as improved quality of life for patients with end-stage renal failure.
|Condition or disease||Intervention/treatment||Phase|
|Palliative Care Renal Failure, End-stage||Behavioral: Transitional community based palliative care||Not Applicable|
Related to the primary aim:
- Are there differences in healthcare utilization between the ESRF patients in the customary care group and those in the HBPRP group; in the HBPRP group and HBPP group?
- Are there differences in evaluated health outcomes (functional status, symptom intensity, and satisfaction with care) between the customary care group and the HBPRP group ; in the HBPRP group and HBPP group?
Are there differences in perceived health outcomes (quality of life, caregiver burden) between the customary care group and the HBPRP group; in the HBPRP group and HBPP group?
Related to the secondary aim:
- How are the lived experiences compared and contrasted between the customary care group and the HBPRP group; in the HBPRP group and HBPP group?
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||76 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Effects of a Transitional Palliative Care Model on Patients With ESRF|
|Study Start Date :||August 2014|
|Actual Primary Completion Date :||September 2017|
|Actual Study Completion Date :||November 2018|
Experimental: Transitional Palliative Care
Transitional palliative care include:-
Behavioral: Transitional community based palliative care
transitional palliative care include:-
Other Name: Transitional palliative care
No Intervention: Customary care
Customary care receive care :-
- Healthcare utilization composite - The dates of re-hospitalizations, length of stay, and number of other hospital services used, including clinics and emergency room visits, will be extracted from the hospital administrative systems. [ Time Frame: for 12 months ]
- Evaluated health outcomes composite (functional status, symptom intensity) - The functional status will be measured by the Palliative Performance Scale (PPS )(appendix 6). [ Time Frame: 12 months ]The PPS is a clinical tool commonly used in the local settings. The level of physical performance is rated on a scale of 100 (normal) to 0 (death), measured in 10 % decrement levels. The scale has been validated and the inter-rater reliability between doctors and nurses maintained at .85 with strong kappa values of .97 (Myers J, Gardiner K, Harris K et al., 2010).
- Perceived outcomes composite (quality of life, caregiver burden, satisfaction with care) [ Time Frame: 12 months ]Quality of life will be measured by an ESRF-specific quality of life measure. The caregiver burden will be measured by the Zarit Caregiver Burden Scale (ZCBS). Satisfaction with care will be measured by the 15-item questionnaire
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02139917
|Queen Elizabeth Hospital|
|Hong Kong, Hong Kong SAR, Hong Kong, 852|